Further studies on the mechanism by which IDH mutation drives integrin expression and understanding the functions of IDH1mut-upregulated integrins may help identify additional novel targets for treating patients with IDH1-mutant chondrosarcomas. The gene discussed is IDH2; the disease is chondrosarcoma.